Advent closes new fund with L145.5M

European VC firm Advent Venture Partners closed Advent Life Sciences Fund II with L145.5 million ($234.3 million). The fund came from new and existing LPs, including funds-of-funds, pension funds and family offices.

Advent, which raised its first life sciences fund in two closes in 2010 and 2012 totaling L101.3 million ($158.4 million), invests predominately in early and mid-stage life science companies in the U.S. and Europe, with a focus on new drug discovery, enabling technologies, and medtech and diagnostics. ...